May 16, 2018 / 5:24 AM / 4 months ago

BRIEF-Novartis says set to deliver sales growth, margin expansion through 2022

May 16 (Reuters) - Novartis AG:

* SAYS POSITIONED TO DELIVER SALES GROWTH AND MARGIN EXPANSION THROUGH 2022

* SAYS ALCON RETURNING TO A POSITION OF STRENGTH AS WORLD'S LEADING EYE CARE DEVICES COMPANY

* CEO SAYS FIRM MADE MISTAKES RECENTLY AND WORLD RIGHTLY EXPECTS MORE FROM A LEADING HEALTHCARE COMPANY

* SAYS DESPITE CONTINUING US PRICING PRESSURE, GLOBALLY, SANDOZ GROSS MARGIN IS IMPROVING

* SAYS IN US, SANDOZ IS OPTIMIZING PORTFOLIO THROUGH TARGETED PRUNING AND LEARNING FROM RECENT SETBACKS

* SAYS MANAGEMENT HIGHLIGHTS ACTIONS THAT HAVE RETURNED BUSINESS TO GROWTH AND IMPROVED MARGINS

* SAYS ALCON STRATEGIC REVIEW IS ON TRACK WITH ACTION NOT EXPECTED BEFORE FIRST HALF OF 2019

* SAYS ALCON EXPECTS TO RETURN TO LONG-TERM, SUSTAINABLE GROWTH WITH MARGINS IN LINE WITH INDUSTRY PEERS Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below